title: Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
authors.affiliation: Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Northern Ireland.
authors.forename: A J
authors.initials: AJ
authors.lastname: McKnight
authors.forename: A
authors.initials: A
authors.lastname: Shaw
authors.forename: C E
authors.initials: CE
authors.lastname: Goldsmith
authors.forename: L
authors.initials: L
authors.lastname: Clarke
authors.forename: B C
authors.initials: BC
authors.lastname: Millar
authors.forename: J
authors.initials: J
authors.lastname: McCaughan
authors.forename: J S
authors.initials: JS
authors.lastname: Elborn
authors.forename: A
authors.initials: A
authors.lastname: Reid
authors.forename: J E
authors.initials: JE
authors.lastname: Moore
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods; D015242:Ofloxacin / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D020615:Stenotrophomonas maltophilia / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D064704:Levofloxacin; D015242:Ofloxacin